0001640455-21-000028.txt : 20210203
0001640455-21-000028.hdr.sgml : 20210203
20210203174647
ACCESSION NUMBER: 0001640455-21-000028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210203
DATE AS OF CHANGE: 20210203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Drapkin Kimberlee C
CENTRAL INDEX KEY: 0001340881
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37998
FILM NUMBER: 21587564
MAIL ADDRESS:
STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC.
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jounce Therapeutics, Inc.
CENTRAL INDEX KEY: 0001640455
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 454870634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-259-3840
MAIL ADDRESS:
STREET 1: 780 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wf-form4_161239239254752.xml
FORM 4
X0306
4
2021-02-01
0
0001640455
Jounce Therapeutics, Inc.
JNCE
0001340881
Drapkin Kimberlee C
C/O JOUNCE THERAPEUTICS, INC.
780 MEMORIAL DRIVE
CAMBRIDGE
MA
02139
0
1
0
0
CFO and Treasurer
Common Stock
2021-02-01
4
A
0
22250
0
A
65431
D
Stock Option (Right to Buy)
11.89
2021-02-01
4
A
0
44500
0
A
2031-02-01
Common Stock
44500.0
44500
D
The option will vest quarterly in 16 equal installments following January 1, 2021.
/s/ Kimberlee C. Drapkin
2021-02-03